Abstract：【Objective】To investigate the expression of Slit2 and Robo1 proteins in pancreatic cancer and their relationship with microvessel density (MVD).【Methods】 Immunohistochemical staining SP method was used to detect the expression of Slit2 and Robo1 proteins in 30 cases of pancreatic cancer tissues and 30 cases of adjacent tissues. The expression changes of Slit2 protein and Robo1 protein under different clinicopathological conditions were observed. The microvessel density (MVD) marker CD105 was detected to study the relationship between Slit2 /Robo1 protein expression and MVD in pancreatic cancer. 【Results】The positive rates of Slit2 and Robo1 were 60.00% and 70.00% in pancreatic cancer tissues, respectively; and the positive rates in the adjacent tissues were 33.33% and 40.00%, respectively. The differences between the two types of tissues were statistically significant (P<0.05). There was a positive correlation between the positive expression of Slit2 protein and Robo1 protein (r=0.818, P< 0.05). The expression of MVD in pancreatic cancer tissues was higher than that in the adjacent tissues (t=9.475, P<0.05). The MVD in pancreatic cancer tissues with positive expression of Slit2 and Robo1 was much higher than that in pancreatic cancer tissues with negative expression of Slit2 and Robot1 (t=2.048, P<0.05,t=2.897, P<0.05). Expression of Slit2, Robo1 and MVD were significantly associated with tumor size, pathological type, clinical stage, and lymph node metastasis of pancreatic cancer (P<0.05).【Conclusion】 The increased expression of Slit2 protein and Robo1 protein in pancreatic cancer tissue is closely related to the growth, invasion and metastasis of pancreatic cancer. The mechanism may be that Slit2/Robo1 signaling pathway promotes the occurrence and development of pancreatic cancer by inducing tumor angiogenesis. The expression intensity of Slit2 /Robo1 and the enumerations of MVD can be used to predict the progression and prognosis of pancreatic cancer.
梁刚, 王智翔, 何盟国, 杨学超. Slit2 、Robo1蛋白在胰腺癌组织中的表达及其与微血管密度的关系[J]. 医学临床研究, 2020, 37(1): 95-97.
LIANG Gang, WANG Zhi-xiang, HE Meng-guo,et al. Expression of Slit2 and Robo1 Proteins and their Relationship with Microvessel Density in Pancreatic Carcinoma. JOURNAL OF CLINICAL RESEARCH, 2020, 37(1): 95-97.
[1] London NR, Li DY. Robo4-dependent slit signaling stabilizes the vasculature during pathologic angiogenesis and cytokine storm[J].Curr Opin Hematol,2011, 18(3): 186-190. [2] Rama N, Dubrac A, Mathivet T,et al.Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization[J].Nat Med,2015, 21(5): 483-491. [3] Ballard MS, Hinck L. A roundabout way to cancer[J].Adv Cancer Res,2012, 114: 187-235. [4] 梁刚,何盟国,马清涌.Slit/Robo信号通路在胰腺癌细胞中的表达及其对胰腺癌细胞生长的影响 [J].癌症进展,2016,14(2):150-154. [5] 高雪莲. 新辅助化疗对宫颈癌患者外周血Treg细胞、血清TGF-β1、VEGF水平及组织VEGF、CD105表达的影响 [J].医学临床研究, 2018,35(4):651-653. [6] Feng Y, Feng L, Yu D,et al.SrGAP1 mediates the migration inhibition effect of Slit2-Robo1 in colorectal cancer[J].J Exp Clin Cancer Res,2016, 35(1): 191. [7] Huang Z, Wen P, Kong R,et al.USP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration[J].Int J Cancer,2015, 136(8): 1792-1802. [8] Wang B, Xiao Y, Ding BB,et al.Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity[J].Cancer Cell,2003, 4(1): 19-29. [9] Wikstrom P, Lissbrant IF, Stattin P,et al.Endoglin(CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer[J].Prostate,2002,51(4):268-275. [10] Stella M, Trusolino L, Comoglio PM. The Slit/Robo system suppresses hepatocyte growth factor-dependent invasion and morphogenesis[J].Mol Biol Cell,2009,20(2):642-657. [11] Enomoto S, Mitsui K, Kawamura T,et al.Suppression of Slit2/robo1 mediated huvec migration by Robo4[J].Biochem Biophys Res Commun,2016, 469(4): 797-802.
2020, Vol. 37 
